Vakona

Private

UmeåHealthcare & Life Scienceshttps://vakona.se/

Last Round

VC Round

Apr 28, 2025

Total Funding Raised

$1.73M

Company Overview

Vakona is a pharmaceutical company developing a novel, antibiotic-free treatment for acne vulgaris by targeting bacterial biofilms.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologyacne treatmentdrug discoverytopical drugantibiotic-freebiofilmdermatologyacne vulgarispreclinical developmentbiotech startupmicrobiomepharma R&Dskincare techdrug candidate

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Vakona Comps

Public and private peers based on sector, stage, and business model.

Vakona comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Vakona Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
VC Round	Apr 28, 2025
VC Round	Mar 29, 2023
Seed	Nov 8, 2021

View all Funding Rounds

Key People

Founding team and executive leadership

Gabriella Persson

CEO

Executive Team

Vakona Investors

Notable investors and investment history

Vakona investors
Investor	Rounds
Phase2Phase Biopharma	Seed, VC Round
Stockholm Business Angels	Seed, VC Round
Partnerinvest Norr	Seed, VC Round

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Mar 29, 2023
$1.33M round from Partnerinvest Norr and others.

View all signals

Vakona Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Vakona Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Vakona's valuation, stock price, and market status.

Firmographic Details

HeadquartersUmeå

Employee Range6

Year Founded2020

Last FundingApr 28, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.